X You are viewing the latest eNews for Laboratory Professionals, our weekly email newsletter sent to thousands of professionals and students.

[Return Home]
[Subscribe for Free]
[Become a Sponsor]



NEWS-Line - eNews

Here is your NEWS-Line for Laboratory Professionals eNewsletter. For the latest news, jobs, education and blogs, bookmark our news page and job board or to take us everywhere with you, save this link to your phone. Also, enjoy the latest issue of NEWS-Line magazine, always free.



NEWS:

Latest ADA Annual Standards of Care Includes Changes to Diabetes Screening, First-Line Therapy, Pregnancy, and Technology

The American Diabetes Association® (ADA) released its much-anticipated annual Standards of Medical Care in Diabetes (Standards of Care). Based upon the latest scientific diabetes research and clinical trials, Standards of Care is the gold-standard for professionals in the medical field and includes vital new and updated practice guidelines to care for people with diabetes and prediabetes.

"We recognize that health care providers around the world look to our Standards of Care for the latest in how new research can impact care and are excited to provide this valuable resource," said Dr. Robert Gabbay, Chief Scientific & Medical Officer at the ADA. "The evidence for the prevention and treatment of diabetes and its complications is constantly evolving and it is crucial we do our best to keep medical professionals informed on best practices and medical advances in the field of diabetes."

S

Read Full Article

Post your openings here TODAY!!

NIH Scientists Urge Pursuit Of Universal Coronavirus Vaccine

A growing body of scientific evidence, considered together with ecological reality, strongly suggest that novel coronaviruses will continue to infect bats and other animal reservoirs and potentially emerge to pose a pandemic threat to humans. To counter future coronavirus outbreaks, the global scientific and medical research community should focus a major effort now on three goals: characterize the range of coronavirus genetic diversity in multiple animal species; better understand coronavirus disease pathogenesis in laboratory animal models and people; and apply this knowledge to the development of long-lasting, broadly protective coronavirus vaccines. So argue physician-scientists Anthony S. Fauci, M.D., Jeffery K. Taubenberger, M.D., Ph.D., and David M. Morens, M.D., of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, in a n

Read Full Article

Improving Drug Options For Colorectal Cancer Patients

Patients with colorectal cancer were among the first to receive targeted therapies. These drugs aim to block the cancer-causing proteins that trigger out-of-control cell growth while sparing healthy tissues. But some patients are not eligible for these treatments because they have cancer-promoting mutations that are believed to cause resistance to these drugs.

Now, Salk Assistant Professor and physician-scientist Edward Stites has used computer modeling and cell studies to discover that more patients may be helped by a common class of targeted therapies than previously thought. The findings were published December 14, 2021, in Cell Reports.

“Colorectal cancer patients who have tried all of the standard treatment options but still seen their cancer progress are in need of new options. Our study suggests that one already available targeted therapy could benefit up to 12,000 additional co

Read Full Article

ISPE Publishes First-of-Its-Kind Guide for Advanced Therapy Medicinal Products (ATMPs)

The International Society for Pharmaceutical Engineering (ISPE) announced the release of the ISPE Guide: Advanced Therapy Medicinal Products (ATMPs) – Autologous Cell Therapy, a first-of-its-kind guide about the development and design of manufacturing facilities for ATMPs.

ISPE Guide: ATMPs - Autologous Cell TherapyATMP therapies include cells, engineered tissues, or the manipulation of the patient’s genome. This is in contrast with traditional manufacturing processes for compounds that are synthetically derived (i.e., small molecule) or proteins or peptides expressed by cellular systems (i.e., large molecule biopharmaceuticals). ATMPs are based on genes, cells, or tissues delivered to patients to provide a therapeutic benefit based on a specific target of interest.

The term ATMP is broad and these are emerging therapies that utilize rapidly evolving technology and equipment. In recogn

Read Full Article

More News


LINKS:





UPCOMING EVENTS:


Would you like to be Featured
in NEWS-Line for
Laboratory Professionals?

Click Here